Phase-3 trials to begin on two-dose regimen

In a meeting held last month, the Subject Expert Committee (SEC), which advises the drug regulator-granted permission to the company for conducting Phase III trials on its vaccine.

from Industry-Economic Times
Read The Rest:economictimes...